TTN/CCDC141 is highly expressed in the heart [42], suggesting its potential role in biochemical pathways and cardiovascular health, but it has not yet been discussed under the scope of dyslipidemia and atherogenic indexes. This evidence concerns the gene CCDC141 and metabolic syndrome.